Lymphadenectomy in stage I ovarian cancer
Authors:
- Manfred LahousenMLManfred Lahousen
- Karl TamussinoKTKarl Tamussino
- Hellmuth PickelHPHellmuth Pickel
- Heidi StranzlHSHeidi Stranzl
- Haro StettnerHSHaro Stettner
- Raimund WinterRWRaimund Winter
- 1 February 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (2) , 656-662
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapseAmerican Journal of Obstetrics and Gynecology, 1993
- Ovarian cancer staging: Does it require a gynecologic oncologist?Gynecologic Oncology, 1992
- Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five‐year cancer registry reviewBJOG: An International Journal of Obstetrics & Gynaecology, 1992
- A phase II trial of adjuvant cisplatin and doxorubicin in Stage I epithelial ovarian cancerGynecologic Oncology, 1991
- Stage I ovarian epithelial carcinoma: Survival analysis following definitive treatmentGynecologic Oncology, 1991
- Patterns of pelvic and paraaortic lymph node involvement in ovarian cancerGynecologic Oncology, 1991
- Combination chemotherapy in radically operated advanced ovarian cancerCancer Treatment Reviews, 1990
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Ovarian cancer stages I and II: Predictions and 5-year survival in two decadesGynecologic Oncology, 1989
- Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovaryGynecologic Oncology, 1983